You are here
Mitohealth, Inc
UEI: N/A
# of Employees: 2
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of a lasmiditan analogue for treatment of acute kidney injury
Amount: $232,938.00DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a safe and efficacious therapeutic small molecule for treatment of acute kidney injury (AKI). AKI results from div ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Inducers of Mitochondrial Biogenesis
Amount: $312,053.00DESCRIPTION (provided by applicant): The long-term goal of this project is to identify and develop drugs that induce mitochondrial biogenesis. A variety of diverse acute insults such as ischemia/reper ...
SBIRPhase I2011Department of Health and Human Services National Institutes of Health -
High Throughput Mitochondrial Nephrotoxicant Assay
Amount: $1,608,122.00DESCRIPTION (provided by applicant): The kidney is a target of toxicity from drugs, and industrial and environmental chemicals because of its high blood flow, numerous transporters, and reliance on a ...
SBIRPhase II2011Department of Health and Human Services National Institutes of Health